ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-9I14521
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global ICAD Intracranial Atherosclerotic Disease Pathology Treatment Market Research Report 2023
BUY CHAPTERS

ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-9I14521
Report
October 2024
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Stryker
Balt
Terumo
MicroPort
Acandis GmbH

ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment - Market Size

The global market for ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment was estimated to be worth US$ 190 million in 2023 and is forecast to a readjusted size of US$ 373.8 million by 2030 with a CAGR of 10.0% during the forecast period 2024-2030

ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment - Market

ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment - Market

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment by region & country, by Type, and by Application.
The ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment.
Market Segmentation

Scope of ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment - Market Report

Report Metric Details
Report Name ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment - Market
Forecasted market size in 2030 US$ 373.8 million
CAGR 10.0%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Hospital
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Stryker, Balt, TERUMO, MicroPort, Acandis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment - Market size in 2030?

Ans: The ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment - Market size in 2030 will be US$ 373.8 million.

Who are the main players in the ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment - Market report?

Ans: The main players in the ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment - Market are Stryker, Balt, TERUMO, MicroPort, Acandis

What are the Application segmentation covered in the ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment - Market report?

Ans: The Applications covered in the ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment - Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment - Market report?

Ans: The Types covered in the ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment - Market report are Stent, PTA Balloon

Recommended Reports

Cardiovascular & Cerebrovascular

Neurovascular Disorders

Neurological Diseases

1 Market Overview
1.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Product Introduction
1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size Forecast
1.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Trends & Drivers
1.3.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Industry Trends
1.3.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Drivers & Opportunity
1.3.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Challenges
1.3.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Players Revenue Ranking (2023)
2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue by Company (2019-2024)
2.3 Key Companies ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment
2.6 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Competitive Analysis
2.6.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Stent
3.1.2 PTA Balloon
3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Type
3.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value, by Type (2019-2030)
3.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Application
4.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value, by Application (2019-2030)
4.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Region
5.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Region (2019-2024)
5.1.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Region (2025-2030)
5.1.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value, 2019-2030
5.2.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value, 2019-2030
5.3.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value, 2019-2030
5.5.2 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value
6.3 United States
6.3.1 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value, 2019-2030
6.3.2 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value, 2019-2030
6.4.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value, 2019-2030
6.5.2 China ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value, 2019-2030
6.6.2 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value, 2019-2030
6.7.2 South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value, 2019-2030
6.9.2 India ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Stryker
7.1.1 Stryker Profile
7.1.2 Stryker Main Business
7.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Products, Services and Solutions
7.1.4 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Stryker Recent Developments
7.2 Balt
7.2.1 Balt Profile
7.2.2 Balt Main Business
7.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Products, Services and Solutions
7.2.4 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Balt Recent Developments
7.3 TERUMO
7.3.1 TERUMO Profile
7.3.2 TERUMO Main Business
7.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Products, Services and Solutions
7.3.4 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 MicroPort Recent Developments
7.4 MicroPort
7.4.1 MicroPort Profile
7.4.2 MicroPort Main Business
7.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Products, Services and Solutions
7.4.4 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 MicroPort Recent Developments
7.5 Acandis
7.5.1 Acandis Profile
7.5.2 Acandis Main Business
7.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Products, Services and Solutions
7.5.4 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Acandis Recent Developments
8 Industry Chain Analysis
8.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Industrial Chain
8.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Model
8.5.2 Sales Channel
8.5.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
Stryker
Balt
Terumo
MicroPort
Acandis GmbH
List of Tables
    Table 1. ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Trends
    Table 2. ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Drivers & Opportunity
    Table 3. ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Challenges
    Table 4. ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Restraints
    Table 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Product Type
    Table 9. Key Companies Time to Begin Mass Production of ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment
    Table 10. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Region (2019-2024) & (%)
    Table 27. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value, (2025-2030) & (US$ Million)
    Table 31. Stryker Basic Information List
    Table 32. Stryker Description and Business Overview
    Table 33. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Products, Services and Solutions
    Table 34. Revenue (US$ Million) in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business of Stryker (2019-2024)
    Table 35. Stryker Recent Developments
    Table 36. Balt Basic Information List
    Table 37. Balt Description and Business Overview
    Table 38. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Products, Services and Solutions
    Table 39. Revenue (US$ Million) in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business of Balt (2019-2024)
    Table 40. Balt Recent Developments
    Table 41. TERUMO Basic Information List
    Table 42. TERUMO Description and Business Overview
    Table 43. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Products, Services and Solutions
    Table 44. Revenue (US$ Million) in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business of TERUMO (2019-2024)
    Table 45. TERUMO Recent Developments
    Table 46. MicroPort Basic Information List
    Table 47. MicroPort Description and Business Overview
    Table 48. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Products, Services and Solutions
    Table 49. Revenue (US$ Million) in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business of MicroPort (2019-2024)
    Table 50. MicroPort Recent Developments
    Table 51. Acandis Basic Information List
    Table 52. Acandis Description and Business Overview
    Table 53. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Products, Services and Solutions
    Table 54. Revenue (US$ Million) in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business of Acandis (2019-2024)
    Table 55. Acandis Recent Developments
    Table 56. Key Raw Materials Lists
    Table 57. Raw Materials Key Suppliers Lists
    Table 58. ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Downstream Customers
    Table 59. ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Distributors List
    Table 60. Research Programs/Design for This Report
    Table 61. Key Data Information from Secondary Sources
    Table 62. Key Data Information from Primary Sources
    Table 63. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Product Picture
    Figure 2. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 4. ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Report Years Considered
    Figure 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue in 2023
    Figure 7. ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Stent Picture
    Figure 9. PTA Balloon Picture
    Figure 10. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Hospital
    Figure 13. Product Picture of Clinic
    Figure 14. Product Picture of Other
    Figure 15. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value (%), (2019-2030)
    Figure 28. United States ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 34. China ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 36. China ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 46. India ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 48. India ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 49. ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Industrial Chain
    Figure 50. ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global ICAD Intracranial Atherosclerotic Disease Pathology Market Insights Forecast to 2030
Intracranial Atherosclerotic Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intracranial Aneurysm Treatment Market Insights Forecast to 2030
Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Market Research Report 2024
Global Atherosclerosis Therapeutics Market Insights Forecast to 2030
Intracranial Stent System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Brain Ischemia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intracranial Stents Market Research Report 2025
Global Cerebral Infarction Therapy Market Insights Forecast to 2030
Global Cerebrovascular Disease Market Research Report 2024
Global Balloon expanded Intracranial Stents Market Research Report 2024
Global Ischemic Neurointerventional Device Market Research Report 2025
Global Coronary Artery Disease Therapeutics Market Research Report 2024
Intrasaccular Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ischemic Cerebrovascular Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global AI Medical Imaging Software for Chronic Cerebrovascular Diseases Market Research Report 2024
Global Self expandable Intracranial Stents Market Research Report 2024
Global Peripheral Artery Disease Treatment Devices Market Research Report 2024
Global Diagnostics of Peripheral Arterial Disease Market Research Report 2025
Global Acute Ischemic Stroke Drugs Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions